The following parameters are measured at Inclusion, Week 2, Week 4, Week 8 and Week 12 of the study: [clinicaltrials_resource:4ad16bb5460ba7982ac19a8bb4ddcc84]

The following parameters are measured at Inclusion, Week 2, Week 4, Week 8 and Week 12 of the study: [clinicaltrials_resource:4ad16bb5460ba7982ac19a8bb4ddcc84]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:4ad16bb5460ba7982ac19a8bb4ddcc84
Botulinum Toxin Type A (Dysport) Associated With Rehabilitation Treatment in Patients With Primary Myofascial Pain Syndrome [clinicaltrials:NCT00149240]
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

The following parameters are measured at Inclusion, Week 2, Week 4, Week 8 and Week 12 of the study: [clinicaltrials_resource:4ad16bb5460ba7982ac19a8bb4ddcc84]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:4ad16bb5460ba7982ac19a8bb4ddcc84
Bio2RDF identifier
4ad16bb5460ba7982ac19a8bb4ddcc84
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:4ad16bb5460ba7982ac19a8bb4ddcc84
measure [clinicaltrials_vocabulary:measure]
The following parameters are m ...... ek 8 and Week 12 of the study:
identifier
clinicaltrials_resource:4ad16bb5460ba7982ac19a8bb4ddcc84
title
The following parameters are m ...... ek 8 and Week 12 of the study:
@en
inDataset
type
label
The following parameters are m ...... 16bb5460ba7982ac19a8bb4ddcc84]
@en